These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Working memory binding and episodic memory formation in aging, mild cognitive impairment, and Alzheimer's dementia. van Geldorp B; Heringa SM; van den Berg E; Olde Rikkert MG; Biessels GJ; Kessels RP J Clin Exp Neuropsychol; 2015; 37(5):538-48. PubMed ID: 26011711 [TBL] [Abstract][Full Text] [Related]
3. Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults. Pettigrew C; Soldan A; Moghekar A; Wang MC; Gross AL; O'Brien R; Albert M Neuropsychologia; 2015 Nov; 78():63-72. PubMed ID: 26394023 [TBL] [Abstract][Full Text] [Related]
4. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults. Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697 [TBL] [Abstract][Full Text] [Related]
5. Process dissociation analyses of memory changes in healthy aging, preclinical, and very mild Alzheimer disease: Evidence for isolated recollection deficits. Millar PR; Balota DA; Maddox GB; Duchek JM; Aschenbrenner AJ; Fagan AM; Benzinger TLS; Morris JC Neuropsychology; 2017 Oct; 31(7):708-723. PubMed ID: 28206782 [TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer's Disease Trajectory and Relationships with Cognitive Function. Sundermann EE; Campbell LM; Villers O; Bondi MW; Gouaux B; Salmon DP; Galasko D; Soontornniyomkij V; Ellis RJ; Moore DJ Viruses; 2023 Jun; 15(6):. PubMed ID: 37376619 [TBL] [Abstract][Full Text] [Related]
7. Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition. Cullen NC; Mälarstig AN; Stomrud E; Hansson O; Mattsson-Carlgren N Sci Rep; 2021 Jan; 11(1):1965. PubMed ID: 33479445 [TBL] [Abstract][Full Text] [Related]
10. Subthreshold Amyloid Predicts Tau Deposition in Aging. Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045 [TBL] [Abstract][Full Text] [Related]
11. Increased intraindividual variability in reaction time performance is associated with emerging cognitive decline in cognitively unimpaired adults. Jutten RJ; Amariglio RE; Maruff P; Properzi MJ; Rentz DM; Johnson KA; Sperling RA; Papp KV Neuropsychology; 2024 Feb; 38(2):184-197. PubMed ID: 37971861 [TBL] [Abstract][Full Text] [Related]
12. Executive functions in patients with Alzheimer's disease, type 2 diabetes mellitus patients and cognitively healthy older adults. Redondo MT; Beltrán-Brotóns JL; Reales JM; Ballesteros S Exp Gerontol; 2016 Oct; 83():47-55. PubMed ID: 27451340 [TBL] [Abstract][Full Text] [Related]
13. Diffusion tensor imaging correlates of cognitive-motor decline in normal aging and increased Alzheimer's disease risk. Hawkins KM; Goyal AI; Sergio LE J Alzheimers Dis; 2015; 44(3):867-78. PubMed ID: 25374102 [TBL] [Abstract][Full Text] [Related]
14. Aging attitudes and changes in the costs of cognitive engagement in older adults over 5 years. Hess TM; Neupert SD; Lothary AF Psychol Aging; 2022 Jun; 37(4):456-468. PubMed ID: 35617229 [TBL] [Abstract][Full Text] [Related]
15. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900 [TBL] [Abstract][Full Text] [Related]
16. Social Engagement and Amyloid-β-Related Cognitive Decline in Cognitively Normal Older Adults. Biddle KD; d'Oleire Uquillas F; Jacobs HIL; Zide B; Kirn DR; Rentz DM; Johnson KA; Sperling RA; Donovan NJ Am J Geriatr Psychiatry; 2019 Nov; 27(11):1247-1256. PubMed ID: 31248770 [TBL] [Abstract][Full Text] [Related]
17. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study. Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM Elife; 2023 Jan; 12():. PubMed ID: 36607335 [TBL] [Abstract][Full Text] [Related]
18. Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer's disease. Ronat L; Hanganu A; Chylinski D; Van Egroo M; Narbutas J; Besson G; Muto V; Schmidt C; Bahri MA; Phillips C; Salmon E; Maquet P; Vandewalle G; Collette F; Bastin C J Neurol; 2024 Apr; 271(4):2067-2077. PubMed ID: 38114820 [TBL] [Abstract][Full Text] [Related]
19. Domain-specific cognitive effects of white matter pathology in old age, mild cognitive impairment and Alzheimer's disease. Kaskikallio A; Karrasch M; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 May; 27(3):453-470. PubMed ID: 31198088 [TBL] [Abstract][Full Text] [Related]